Skip to content

Snapshot of Our World Class Speaker Faculty

Alessio Ciulli

Professor of Structural Chemical Biology

University of Dundee

Georg Winter

Principal Investigator

CeMM Research Centre for Molecular Medicine

John Harling

Senior Scientific Director of Medicinal Chemistry

GlaxoSmithKline

Raj Chopra

Director of Cancer Research UK Cancer Therapeutics Unit; Head of Division of Cancer Therapeutics

The Institute of Cancer Research

Brian Jones

Chief Scientific Officer

Cedilla Therapeutics

Joerg Rinnenthal

Principal Scientist

Boehringer Ingelheim

Laura Itzhaki

Professor, University of Cambridge; Chief Scientific Officer

PolyProx Therapeutics

Paul Thompson

Vice President of Clinical Development

Mission Therapeutics

Despite the exciting clinical progression of PROTAC-based therapies, much of the fundamental biology and chemistry in the field is still unknown, with many discovery and development challenges still holding back the translation of robust candidates into the clinic.

The Inaugural Targeted Protein Degradation Europe 2020, as your forward looking and industry dedicated platform, will be bringing together key European and international experts in the field of protein degradation to capture the most pioneering data, thought provoking insights and practical lessons learned, enabling you to maximise the therapeutic window of your TPD strategy.

Built with large pharma and biotech insight, Targeted Protein Degradation Europe 2020 focuses on expanding the fundamental understanding of protein degradation in order to validate the next generation of druggable targets, optimise drug-like properties and leverage degradation pathways beyond the ubiquitin-proteasome system to accelerate robust translation of TPD candidates for clinical trials in oncology and neurodegenerative diseases.

View the full event guide for further details on speakers, content and how to join those who are re-defining the targeted protein degradation field.

TPD Series Previous Attendees

arvinas logo
Celgene-logo-Commited-to-Patients
novartis-logo-preview-image
Pfizer.svg
C4Therapeutics-Logo
Cedilla Therapeutics
Merck-1440x960
1200px-Hoffmann-La_Roche_logo.svg
Sanofi
images
astrazeneca
Amgen
genentech-logo
abbvie-logo-big
Nurix

Confirmed Partners 2020

admin-ajax
Proteome-Sciences-Plc

Other Events In The Undruggable Series